Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lexington, KY
NPI
1396911624
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1221 S Broadway, Endocrinology Dept.
Lexington, KY, 40504
Phone (859) 258-4401
Groups this clinician bills Medicare through
Medicare paid, 2024
$461K
24,910 services
Medicare patients, 2024
1,756
Average age 74
Drug cost, 2024
$3.3M
9,393 prescriptions
Company payments, 2025
$576
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Walaa A Ayoub was code J0897 (injection, denosumab, 1 mg), 12,842 times for 127 patients. In total Walaa A Ayoub billed 24,910 services in 25 codes, and Medicare paid $461K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 12,842 | 127 | $20.33 | $261K |
| 77080 Standard X-ray | Office | 1,255 | 1,255 | $35.66 | $45K |
| 99213 Office E&M - Established | Office | 541 | 407 | $58.18 | $31K |
| 82962 Clinical Chemistry | Office | 498 | 231 | $3.08 | $1,532 |
| 83036 Blood Count | Office | 468 | 225 | $9.13 | $4,271 |
| 99214 Office E&M - Established | Office | 409 | 282 | $85.34 | $35K |
| 96372 Injection Administration | Office | 311 | 137 | $9.42 | $2,931 |
| 77089 Standard X-ray | Office | 160 | 160 | $28.33 | $4,533 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 61 | 58 | $12.72 | $776 |
| 99203 Office E&M - New | Office | 60 | 60 | $75.39 | $4,524 |
| 10005 Other Organ Systems | Office | 52 | 52 | $98.13 | $5,103 |
| 99204 Office E&M - New | Office | 20 | 20 | $108.08 | $2,162 |
| 77081 Standard X-ray | Office | 18 | 18 | $29.40 | $529 |
| 10006 Other Organ Systems | Office | 16 | 16 | $46.79 | $749 |
| 99202 Office E&M - New | Office | 15 | 15 | $51.69 | $775 |
By year: 2022 $271K for 13,059 services; 2023 $423K for 23,718 services; 2024 $461K for 24,910 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 498 | 231 | $3.08 | $1,532 |
| 83036 Blood Count | 468 | 225 | $9.13 | $4,271 |
Medicare prescription drug claims, 2024
In 2024, the drug Walaa A Ayoub prescribed most often to Medicare patients was Levothyroxine Sodium, with 839 prescriptions and refills. In total Walaa A Ayoub wrote 9,393 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 839 | 2,251 | 245 | $8,528 |
| Ozempic Semaglutide | 635 | 802 | 130 | $753K |
| Metformin Hcl Generic | 460 | 1,309 | 160 | $3,679 |
| Synthroid Levothyroxine Sodium | 450 | 1,123 | 112 | $39K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 348 | 771 | 117 | $61K |
| Alendronate Sodium Generic | 339 | 833 | 104 | $2,187 |
| Jardiance Empagliflozin | 308 | 615 | 78 | $350K |
| Methimazole Generic | 295 | 590 | 73 | $2,980 |
| Glimepiride Generic | 284 | 672 | 75 | $2,204 |
| Pioglitazone Hcl Generic | 264 | 688 | 80 | $2,876 |
| Glipizide Generic | 248 | 683 | 78 | $2,674 |
| Metformin Hcl Er Metformin Hcl | 238 | 621 | 73 | $3,431 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 193 | 456 | 78 | $19K |
| Novolog Flexpen Insulin Aspart | 187 | 392 | 67 | $57K |
| Atorvastatin Calcium Generic | 181 | 531 | 63 | $1,593 |
Brand drugs: 4,566 claims; generic drugs: 4,029 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Walaa A Ayoub $576 ($576 in general payments such as food, travel and fees) from 16 companies. The largest payer was W. L. Gore & Associates, Inc. with $114.
| Company | Payments | Amount |
|---|---|---|
| W. L. Gore & Associates, Inc. | 1 | $114 |
| Abbott Laboratories ABT | 3 | $53.51 |
| Insulet Corporation PODD | 3 | $49.49 |
| Novo Nordisk Inc NVO | 2 | $47.35 |
| Sequel Med Tech, LLC | 2 | $40.74 |
| Amgen Inc. AMGN | 2 | $39.67 |
| Lilly USA, LLC LLY | 2 | $36.41 |
| Madrigal Pharmaceuticals MDGL | 2 | $35.98 |
| Ionis Pharmaceuticals, Inc. IONS | 1 | $26.48 |
| Verity Pharmaceuticals Inc. | 1 | $23.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.